Islet Amyloid Polypeptide Market, Global Outlook and Forecast 2022-2028

Islet Amyloid Polypeptide Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281438 | No. of Pages: 70 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Islet Amyloid Polypeptide in global, including the following market information:
Global Islet Amyloid Polypeptide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Islet Amyloid Polypeptide Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Islet Amyloid Polypeptide companies in 2021 (%)
The global Islet Amyloid Polypeptide market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
AC-253 Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Islet Amyloid Polypeptide include Adocia SAS, AstraZeneca Plc, Eli Lilly and Co, Neurimmune Holding AG, Nordic Bioscience A/S, Prothena Corp Plc, reMYND NV and Zealand Pharma AS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Islet Amyloid Polypeptide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Islet Amyloid Polypeptide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Islet Amyloid Polypeptide Market Segment Percentages, by Type, 2021 (%)
    AC-253
    DACRA-042
    DACRA-089
    KBP-056
    KBP-088
    Others
Global Islet Amyloid Polypeptide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Islet Amyloid Polypeptide Market Segment Percentages, by Application, 2021 (%)
    Metabolic Disorders
    Gastrointestinal
    Musculoskeletal Disorders
    Others
Global Islet Amyloid Polypeptide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Islet Amyloid Polypeptide Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Islet Amyloid Polypeptide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Islet Amyloid Polypeptide revenues share in global market, 2021 (%)
Key companies Islet Amyloid Polypeptide sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Islet Amyloid Polypeptide sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Adocia SAS
    AstraZeneca Plc
    Eli Lilly and Co
    Neurimmune Holding AG
    Nordic Bioscience A/S
    Prothena Corp Plc
    reMYND NV
    Zealand Pharma AS
1 Introduction to Research & Analysis Reports
    1.1 Islet Amyloid Polypeptide Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Islet Amyloid Polypeptide Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Islet Amyloid Polypeptide Overall Market Size
    2.1 Global Islet Amyloid Polypeptide Market Size: 2021 VS 2028
    2.2 Global Islet Amyloid Polypeptide Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Islet Amyloid Polypeptide Sales: 2017-2028
3 Company Landscape
    3.1 Top Islet Amyloid Polypeptide Players in Global Market
    3.2 Top Global Islet Amyloid Polypeptide Companies Ranked by Revenue
    3.3 Global Islet Amyloid Polypeptide Revenue by Companies
    3.4 Global Islet Amyloid Polypeptide Sales by Companies
    3.5 Global Islet Amyloid Polypeptide Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Islet Amyloid Polypeptide Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Islet Amyloid Polypeptide Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Islet Amyloid Polypeptide Players in Global Market
        3.8.1 List of Global Tier 1 Islet Amyloid Polypeptide Companies
        3.8.2 List of Global Tier 2 and Tier 3 Islet Amyloid Polypeptide Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Islet Amyloid Polypeptide Market Size Markets, 2021 & 2028
        4.1.2 AC-253
        4.1.3 DACRA-042
        4.1.4 DACRA-089
        4.1.5 KBP-056
        4.1.6 KBP-088
        4.1.7 Others
    4.2 By Type - Global Islet Amyloid Polypeptide Revenue & Forecasts
        4.2.1 By Type - Global Islet Amyloid Polypeptide Revenue, 2017-2022
        4.2.2 By Type - Global Islet Amyloid Polypeptide Revenue, 2023-2028
        4.2.3 By Type - Global Islet Amyloid Polypeptide Revenue Market Share, 2017-2028
    4.3 By Type - Global Islet Amyloid Polypeptide Sales & Forecasts
        4.3.1 By Type - Global Islet Amyloid Polypeptide Sales, 2017-2022
        4.3.2 By Type - Global Islet Amyloid Polypeptide Sales, 2023-2028
        4.3.3 By Type - Global Islet Amyloid Polypeptide Sales Market Share, 2017-2028
    4.4 By Type - Global Islet Amyloid Polypeptide Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Islet Amyloid Polypeptide Market Size, 2021 & 2028
        5.1.2 Metabolic Disorders
        5.1.3 Gastrointestinal
        5.1.4 Musculoskeletal Disorders
        5.1.5 Others
    5.2 By Application - Global Islet Amyloid Polypeptide Revenue & Forecasts
        5.2.1 By Application - Global Islet Amyloid Polypeptide Revenue, 2017-2022
        5.2.2 By Application - Global Islet Amyloid Polypeptide Revenue, 2023-2028
        5.2.3 By Application - Global Islet Amyloid Polypeptide Revenue Market Share, 2017-2028
    5.3 By Application - Global Islet Amyloid Polypeptide Sales & Forecasts
        5.3.1 By Application - Global Islet Amyloid Polypeptide Sales, 2017-2022
        5.3.2 By Application - Global Islet Amyloid Polypeptide Sales, 2023-2028
        5.3.3 By Application - Global Islet Amyloid Polypeptide Sales Market Share, 2017-2028
    5.4 By Application - Global Islet Amyloid Polypeptide Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Islet Amyloid Polypeptide Market Size, 2021 & 2028
    6.2 By Region - Global Islet Amyloid Polypeptide Revenue & Forecasts
        6.2.1 By Region - Global Islet Amyloid Polypeptide Revenue, 2017-2022
        6.2.2 By Region - Global Islet Amyloid Polypeptide Revenue, 2023-2028
        6.2.3 By Region - Global Islet Amyloid Polypeptide Revenue Market Share, 2017-2028
    6.3 By Region - Global Islet Amyloid Polypeptide Sales & Forecasts
        6.3.1 By Region - Global Islet Amyloid Polypeptide Sales, 2017-2022
        6.3.2 By Region - Global Islet Amyloid Polypeptide Sales, 2023-2028
        6.3.3 By Region - Global Islet Amyloid Polypeptide Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Islet Amyloid Polypeptide Revenue, 2017-2028
        6.4.2 By Country - North America Islet Amyloid Polypeptide Sales, 2017-2028
        6.4.3 US Islet Amyloid Polypeptide Market Size, 2017-2028
        6.4.4 Canada Islet Amyloid Polypeptide Market Size, 2017-2028
        6.4.5 Mexico Islet Amyloid Polypeptide Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Islet Amyloid Polypeptide Revenue, 2017-2028
        6.5.2 By Country - Europe Islet Amyloid Polypeptide Sales, 2017-2028
        6.5.3 Germany Islet Amyloid Polypeptide Market Size, 2017-2028
        6.5.4 France Islet Amyloid Polypeptide Market Size, 2017-2028
        6.5.5 U.K. Islet Amyloid Polypeptide Market Size, 2017-2028
        6.5.6 Italy Islet Amyloid Polypeptide Market Size, 2017-2028
        6.5.7 Russia Islet Amyloid Polypeptide Market Size, 2017-2028
        6.5.8 Nordic Countries Islet Amyloid Polypeptide Market Size, 2017-2028
        6.5.9 Benelux Islet Amyloid Polypeptide Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Islet Amyloid Polypeptide Revenue, 2017-2028
        6.6.2 By Region - Asia Islet Amyloid Polypeptide Sales, 2017-2028
        6.6.3 China Islet Amyloid Polypeptide Market Size, 2017-2028
        6.6.4 Japan Islet Amyloid Polypeptide Market Size, 2017-2028
        6.6.5 South Korea Islet Amyloid Polypeptide Market Size, 2017-2028
        6.6.6 Southeast Asia Islet Amyloid Polypeptide Market Size, 2017-2028
        6.6.7 India Islet Amyloid Polypeptide Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Islet Amyloid Polypeptide Revenue, 2017-2028
        6.7.2 By Country - South America Islet Amyloid Polypeptide Sales, 2017-2028
        6.7.3 Brazil Islet Amyloid Polypeptide Market Size, 2017-2028
        6.7.4 Argentina Islet Amyloid Polypeptide Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Islet Amyloid Polypeptide Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Islet Amyloid Polypeptide Sales, 2017-2028
        6.8.3 Turkey Islet Amyloid Polypeptide Market Size, 2017-2028
        6.8.4 Israel Islet Amyloid Polypeptide Market Size, 2017-2028
        6.8.5 Saudi Arabia Islet Amyloid Polypeptide Market Size, 2017-2028
        6.8.6 UAE Islet Amyloid Polypeptide Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Adocia SAS
        7.1.1 Adocia SAS Corporate Summary
        7.1.2 Adocia SAS Business Overview
        7.1.3 Adocia SAS Islet Amyloid Polypeptide Major Product Offerings
        7.1.4 Adocia SAS Islet Amyloid Polypeptide Sales and Revenue in Global (2017-2022)
        7.1.5 Adocia SAS Key News
    7.2 AstraZeneca Plc
        7.2.1 AstraZeneca Plc Corporate Summary
        7.2.2 AstraZeneca Plc Business Overview
        7.2.3 AstraZeneca Plc Islet Amyloid Polypeptide Major Product Offerings
        7.2.4 AstraZeneca Plc Islet Amyloid Polypeptide Sales and Revenue in Global (2017-2022)
        7.2.5 AstraZeneca Plc Key News
    7.3 Eli Lilly and Co
        7.3.1 Eli Lilly and Co Corporate Summary
        7.3.2 Eli Lilly and Co Business Overview
        7.3.3 Eli Lilly and Co Islet Amyloid Polypeptide Major Product Offerings
        7.3.4 Eli Lilly and Co Islet Amyloid Polypeptide Sales and Revenue in Global (2017-2022)
        7.3.5 Eli Lilly and Co Key News
    7.4 Neurimmune Holding AG
        7.4.1 Neurimmune Holding AG Corporate Summary
        7.4.2 Neurimmune Holding AG Business Overview
        7.4.3 Neurimmune Holding AG Islet Amyloid Polypeptide Major Product Offerings
        7.4.4 Neurimmune Holding AG Islet Amyloid Polypeptide Sales and Revenue in Global (2017-2022)
        7.4.5 Neurimmune Holding AG Key News
    7.5 Nordic Bioscience A/S
        7.5.1 Nordic Bioscience A/S Corporate Summary
        7.5.2 Nordic Bioscience A/S Business Overview
        7.5.3 Nordic Bioscience A/S Islet Amyloid Polypeptide Major Product Offerings
        7.5.4 Nordic Bioscience A/S Islet Amyloid Polypeptide Sales and Revenue in Global (2017-2022)
        7.5.5 Nordic Bioscience A/S Key News
    7.6 Prothena Corp Plc
        7.6.1 Prothena Corp Plc Corporate Summary
        7.6.2 Prothena Corp Plc Business Overview
        7.6.3 Prothena Corp Plc Islet Amyloid Polypeptide Major Product Offerings
        7.6.4 Prothena Corp Plc Islet Amyloid Polypeptide Sales and Revenue in Global (2017-2022)
        7.6.5 Prothena Corp Plc Key News
    7.7 reMYND NV
        7.7.1 reMYND NV Corporate Summary
        7.7.2 reMYND NV Business Overview
        7.7.3 reMYND NV Islet Amyloid Polypeptide Major Product Offerings
        7.7.4 reMYND NV Islet Amyloid Polypeptide Sales and Revenue in Global (2017-2022)
        7.7.5 reMYND NV Key News
    7.8 Zealand Pharma AS
        7.8.1 Zealand Pharma AS Corporate Summary
        7.8.2 Zealand Pharma AS Business Overview
        7.8.3 Zealand Pharma AS Islet Amyloid Polypeptide Major Product Offerings
        7.8.4 Zealand Pharma AS Islet Amyloid Polypeptide Sales and Revenue in Global (2017-2022)
        7.8.5 Zealand Pharma AS Key News
8 Global Islet Amyloid Polypeptide Production Capacity, Analysis
    8.1 Global Islet Amyloid Polypeptide Production Capacity, 2017-2028
    8.2 Islet Amyloid Polypeptide Production Capacity of Key Manufacturers in Global Market
    8.3 Global Islet Amyloid Polypeptide Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Islet Amyloid Polypeptide Supply Chain Analysis
    10.1 Islet Amyloid Polypeptide Industry Value Chain
    10.2 Islet Amyloid Polypeptide Upstream Market
    10.3 Islet Amyloid Polypeptide Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Islet Amyloid Polypeptide Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com